Psychiatry & Neurology Doctors in Avon, CT Accepting Medicare

7 Psychiatry & Neurology doctors found. Showing 1 - 7

Dr. Edgardo Lorenzo, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-674-2691    Fax: 860-679-7744

Dr. Alejandro Rangel, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-674-2691

Alma Rosa Barreto, APRN Psychiatry & Neurology - Addiction Medicine Medicare: Accepting Medicare Assignments Practice Location: 65 Avonwood Rd, Apt C9, Avon, CT 06001 Phone: 203-559-6525

Richard Seth Goldberg, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 46 West Avon Rd, Suite 203, Avon, CT 06001 Phone: 860-675-0262

Dr. Abdelmonim Affany, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-674-2691    Fax: 860-677-6443

Yolanda M Pena, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 40 Dale Rd, Ste 104, Avon, CT 06001 Phone: 860-676-8115    Fax: 860-677-6015

Mr. Ibrahim N. Orgun, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 44 Craigemore Cir, Avon, CT 06001 Phone: 860-673-4055

News Archive

Kwashiorkor may be local phenomenon underestimated by national statistics, reveals study

Kwashiorkor, one of the most extreme forms of malnutrition, is estimated to affect more than a hundred thousand children annually.

Poor awareness among parents may hinder a child's early dental care

A new survey has found that one in six parents are likely to postpone their children's dental care visits until the age of 4 or older.

Increased expression of VEGF-A promotes three common aging-related eye conditions

A Massachusetts General Hospital investigator has found that increased expression of the angiogenic factor VEGF-A promotes three common aging-related eye conditions - both versions of age-related macular degeneration (AMD) and also cataracts - in an animal model.

Senesco to present preclinical data of SNS-01 at ASGCT Annual Meeting

Senesco Technologies, Inc. today announced that preclinical data for the Company's lead drug candidate, SNS-01, will be presented on May 20, 2010 at the American Society of Gene and Cell Therapy Annual Meeting being held at the Marriott Wardman Park Hotel in Washington, D.C. from May 17 to 22.

Read more Medical News

› Verified 3 days ago